Md University Of Missouri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Md university of missouri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Md University Of Missouri Today - Breaking & Trending Today

Even When Nearby, Public AEDs Get Little Use in OHCA

Bystander use was zero in at-home OHCAs and < 20% in public, even when an AED was less than a 1-minute walk away. ....

United States , Mirzas Khan , Md Vanderbilt University Medical Center , Md University Of Missouri , American College Of Cardiology , Missouri Kansas City , Vanderbilt University Medical Center , American College , Cardiac Arrest Registry , Enhance Survival , Kansas City ,

The More Tweaks Made to PMA-Approved Devices, the More Likely a Recall

Cardiovascular devices typically account for the lion’s share of supplemental documents, and also see the most recalls. ....

United States , Jonathanr Dubin , Sankets Dhruva , Kushalt Kadakia , San Francisco Veterans Affairs Medical Center , Drug Administration , Msc Harvard Medical School , Md University Of Missouri , University Of California San Francisco , Kansas City , Harvard Medical School , Recall Around , California San Francisco ,

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

The registry data and meta-analysis aren’t definitive, and clearer answers are anticipated from the PROTECTED-TAVR trial. ....

New York , United States , Aamer Ubaid , Arpanjeet Kaur , Samir Kapadia , Sachin Goel , Md University Of Missouri , Drug Administration , Boston Scientific , Nationwide Readmissions Database , Missouri Kansas City , Houston Methodist , Cleveland Clinic , Icahn School , Mount Sinai , Keystone Heart , High Risk For ,

NT-proBNP Test Could Help Guide Hypertension Therapy: ARIC Analysis

February 01, 2021
In people with no history of CV disease, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can predict a higher risk of developing CV disease across various blood pressure and pulse pressure ranges, new data from the Atherosclerosis Risk In Communities (ARIC) study suggest.
The findings raise the possibility of using NT-proBNP tests, which have typically been restricted to the diagnosis and management of heart failure (HF), in the setting of hypertension, researchers say.
Additional information on individual risk could help clinicians refine decisions about therapy, said lead author Aliza Hussain, MD (Baylor College of Medicine, Houston, TX). The most recent hypertension guidelines recommend a treatment goal of less than 130/80 mm Hg across patient groups, she noted, but making a decision to get more aggressive in patients with only moderate hypertension has been a tough sell. ....

United States , Baylor College Of Medicine , Martina Alpert , Haliza Hussain , Md Baylor College Of Medicine , Biomarker Research , School Of Medicine , Md University Of Missouri , Journal Of The American College Cardiology , Atherosclerosis Risk In Communities , Baylor College , Multi Ethnic Study , American College , ஒன்றுபட்டது மாநிலங்களில் , பேலர் கல்லூரி ஆஃப் மருந்து , மார்டினா ஆல்பர்ட் , அலிசா ஹுசைன் , ம்ட் பேலர் கல்லூரி ஆஃப் மருந்து , பயோமார்க் ஆராய்ச்சி , பள்ளி ஆஃப் மருந்து , ம்ட் பல்கலைக்கழகம் ஆஃப் மிச Ou ரி , இதழ் ஆஃப் தி அமெரிக்கன் கல்லூரி இருதயவியல் , பேலர் கல்லூரி , பல இன படிப்பு , அமெரிக்கன் கல்லூரி ,